82 related articles for article (PubMed ID: 33337824)
1. Application Value of Detection of High-Risk HPV Infection in Early Cervical Cancer Patients in Disease Diagnosis and Prognosis Evaluation.
Zhang Y; Wang J; Zhang R; Lei F; Lai S
Clin Lab; 2020 Dec; 66(12):. PubMed ID: 33337824
[TBL] [Abstract][Full Text] [Related]
2. Clinical Value of Human Papillomavirus E6/E7 mRNA Detection in Screening for Cervical Cancer in Women Positive for Human Papillomavirus DNA or.
Han L; Husaiyin S; Zhao F; Rezhake R; Niyazi M
Clin Lab; 2018 Sep; 64(9):1363-1371. PubMed ID: 30274003
[TBL] [Abstract][Full Text] [Related]
3. Diagnostic validity of human papillomavirus E6/E7 mRNA test in cervical cytological samples.
Liu TY; Xie R; Luo L; Reilly KH; He C; Lin YZ; Chen G; Zheng XW; Zhang LL; Wang HB
J Virol Methods; 2014 Feb; 196():120-5. PubMed ID: 24216236
[TBL] [Abstract][Full Text] [Related]
4. [Diagnostic value of human papillomavirus E6/E7 mRNA for residue and recurrence after cervical conization].
Zhao H; Shao H
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2016 Jun; 41(6):606-11. PubMed ID: 27374445
[TBL] [Abstract][Full Text] [Related]
5. Quantivirus® HPV E6/E7 RNA 3.0 assay (bDNA) is as sensitive, but less specific than Hybrid Capture 2 test.
Shen Y; Gong J; He Y; Cheng G; Okunieff P; Li X
J Virol Methods; 2013 Feb; 187(2):288-93. PubMed ID: 23201290
[TBL] [Abstract][Full Text] [Related]
6. [Detection of high-risk human papillomavirus (HPV) E6 and E7 oncogene transcripts increases the specificity of the detection of a cervical intraepithelial neoplasia (CIN)].
Sotlar K; Diemer D; Stubner A; Menton S; Menton M; Dietz K; Wallwiener D; Bültmann B
Verh Dtsch Ges Pathol; 2005; 89():195-200. PubMed ID: 18035691
[TBL] [Abstract][Full Text] [Related]
7. HPV E6/E7 mRNA combined with thin-prep cytology test for the diagnosis of residual/recurrence after loop electrosurgical excision procedure in patients with cervical intraepithelial neoplasia.
Song Y; Zhang M; Zhang C; Du S; Zhai F
Diagn Microbiol Infect Dis; 2024 Jan; 108(1):116119. PubMed ID: 37890308
[TBL] [Abstract][Full Text] [Related]
8. Human papillomavirus (HPV) E6/E7 mRNA detection in cervical exfoliated cells: a potential triage for HPV-positive women.
Yao YL; Tian QF; Cheng B; Cheng YF; Ye J; Lu WG
J Zhejiang Univ Sci B; 2017 Mar.; 18(3):256-262. PubMed ID: 28271661
[TBL] [Abstract][Full Text] [Related]
9. Diagnostic performance of HPV E6/E7 mRNA testing towards HPV-DNA testing and p16/Ki67 immunostaining as a biomarker of high-risk HPV recurrence in Greek women surgically treated for their cervical lesions.
Carcea F; Vavoulidis E; Petousis S; Papandreou P; Siarkou CM; Nasioutziki M; Papanikolaou A; Dinas K; Daniilidis A
J Obstet Gynaecol Res; 2021 Oct; 47(10):3607-3617. PubMed ID: 34374179
[TBL] [Abstract][Full Text] [Related]
10. Diagnostic performance of the E6/E7 mRNA-based Optimygene HR-HPV RT-qDx assay for cervical cancer screening.
Wang HY; Kim H; Park KH
Int J Infect Dis; 2019 Jan; 78():22-30. PubMed ID: 30248464
[TBL] [Abstract][Full Text] [Related]
11. The application of PAX1 methylation detection and HPV E6/E7 mRNA detection in cervical cancer screening.
Li B; Guo R; Lai T; Qiao L; Fu H
J Obstet Gynaecol Res; 2021 Aug; 47(8):2720-2728. PubMed ID: 34036681
[TBL] [Abstract][Full Text] [Related]
12. Clinical Significance of Detection of Human Papilloma Virus DNA and E6/E7 mRNA for Cervical Cancer Patients.
Yu T; Wang C
Cell Mol Biol (Noisy-le-grand); 2022 Feb; 67(6):155-159. PubMed ID: 35818201
[TBL] [Abstract][Full Text] [Related]
13. Detection of HPV E6/E7 mRNA in the diagnosis of cervical cancer and precancerous lesions after kidney transplantation.
Sun J; Yue Y; Li R; Sun Q; Hu C; Ge X; Guan Q
Am J Transl Res; 2021; 13(6):7312-7317. PubMed ID: 34306499
[TBL] [Abstract][Full Text] [Related]
14. Human papillomavirus E6/E7 mRNA testing has higher specificity than liquid-based DNA testing in the evaluation of cervical intraepithelial neoplasia.
Möckel J; Quaas J; Meisel H; Endres AS; Schneider V
Anal Quant Cytol Histol; 2011 Dec; 33(6):311-5. PubMed ID: 22590808
[TBL] [Abstract][Full Text] [Related]
15. Relationship between HPV 16, 18, 31, 33, 45 DNA detection and quantitation and E6/E7 mRNA detection among a series of cervical specimens with various degrees of histological lesions.
Baron C; Henry M; Tamalet C; Villeret J; Richet H; Carcopino X
J Med Virol; 2015 Aug; 87(8):1389-96. PubMed ID: 25908062
[TBL] [Abstract][Full Text] [Related]
16. Comparison of oncogenic HPV type-specific viral DNA load and E6/E7 mRNA detection in cervical samples: results from a multicenter study.
Broccolo F; Fusetti L; Rosini S; Caraceni D; Zappacosta R; Ciccocioppo L; Matteoli B; Halfon P; Malnati MS; Ceccherini-Nelli L
J Med Virol; 2013 Mar; 85(3):472-82. PubMed ID: 23280876
[TBL] [Abstract][Full Text] [Related]
17. Establishment and Application of a Method for High-Risk Human Papillomavirus Genotyping in Cervical Cancer Tissue.
Zou R; Xie W; Wang H; Wang J; Xiao L; Ji S; Chen X; Zhang L; Xue X; Chen J
Clin Lab; 2016; 62(6):1075-85. PubMed ID: 27468570
[TBL] [Abstract][Full Text] [Related]
18. Comparison of the detection of HPV-16, 18, 31, 33, and 45 by type-specific DNA- and E6/E7 mRNA-based assays of HPV DNA positive women with abnormal Pap smears.
Salimović-Bešić I; Tomić-Čiča A; Smailji A; Hukić M
J Virol Methods; 2013 Dec; 194(1-2):222-8. PubMed ID: 24036071
[TBL] [Abstract][Full Text] [Related]
19. RNA extraction method is crucial for human papillomavirus E6/E7 oncogenes detection.
Fontecha N; Nieto MC; Andía D; Cisterna R; Basaras M
Virol J; 2017 Mar; 14(1):50. PubMed ID: 28279212
[TBL] [Abstract][Full Text] [Related]
20. HPV types and E6/E7 mRNA expression in cervical samples from Turkish women with abnormal cytology in Ankara, Turkey.
Tüney İ; Altay A; Ergünay K; Önder SÇ; Usubütün A; Salman MC; Bozdayi G; Karabulut E; Badur OS; Yüce K; Pinar A
Turk J Med Sci; 2017 Feb; 47(1):194-200. PubMed ID: 28263489
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
